Novartis Programs Phase Iii Trial Of Hydroxychloroquine For Covid

Corticosteroids are not generally suggested for treatment of viral pneumonia. The advantage of corticosteroids in septic shock results from tempering the number immune reaction to bacterial toxin release. The incidence of great shock in patients with COVID-19 is relatively low (5% of instances). In america, the period 3 PRESECO research is evaluating utilization in patients… Continue reading Novartis Programs Phase Iii Trial Of Hydroxychloroquine For Covid